{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:59:00Z","timestamp":1770836340683,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00120-023-02065-w","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T15:20:15Z","timestamp":1680621615000},"page":"459-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prostatabiopsie\u00a0\u2013 Infektionsprophylaxe sowie Vorbereitung des Patienten","Prostate biopsy\u2014infection prophylaxis and patient preparation"],"prefix":"10.1007","volume":"62","author":[{"given":"A.","family":"Pilatz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Alidjanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bonkat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Wagenlehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"2065_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-021-03614-8","author":"JF Alidjanov","year":"2021","unstructured":"Alidjanov\u00a0JF, Cai\u00a0T, Bartoletti\u00a0R, Bonkat\u00a0G, Bruyere\u00a0F, Koves\u00a0B et\u00a0al (2021) The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010\u20132019. World J Urol 39(9):3423\u20133432","journal-title":"World J Urol"},{"issue":"10071","key":"2065_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed\u00a0HU, El-Shater Bosaily\u00a0A, Brown\u00a0LC, Gabe\u00a0R, Kaplan\u00a0R, Parmar\u00a0MK et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a\u00a0paired validating confirmatory study. Lancet 389(10071):815\u2013822","journal-title":"Lancet"},{"issue":"2","key":"2065_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.juro.2017.01.103","volume":"198","author":"MA Liss","year":"2017","unstructured":"Liss\u00a0MA, Ehdaie\u00a0B, Loeb\u00a0S, Meng\u00a0MV, Raman\u00a0JD, Spears\u00a0V et\u00a0al (2017) An update of the American urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J\u00a0Urol 198(2):329\u2013334","journal-title":"J Urol"},{"issue":"3","key":"2065_CR4","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/JU.0000000000001425","volume":"205","author":"S Rosenberg","year":"2021","unstructured":"Rosenberg\u00a0S, Bonten\u00a0M, Haazen\u00a0W, Spiessens\u00a0B, Abbanat\u00a0D, Go\u00a0O et al (2021) Epidemiology and O\u2011serotypes of extraintestinal pathogenic escherichia coli disease in patients undergoing transrectal ultrasound prostate biopsy: a prospective multicenter study. J\u00a0Urol 205(3):826\u2013832","journal-title":"J Urol"},{"issue":"4","key":"2065_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijantimicag.2014.01.008","volume":"43","author":"MJ Roberts","year":"2014","unstructured":"Roberts\u00a0MJ, Williamson\u00a0DA, Hadway\u00a0P, Doi\u00a0SAR, Gardiner\u00a0RA, Paterson\u00a0DL (2014) Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis. Int J Antimicrob Agents 43(4):301\u2013309","journal-title":"Int J Antimicrob Agents"},{"key":"2065_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001399","author":"B Pradere","year":"2020","unstructured":"Pradere\u00a0B, Veeratterapillay\u00a0R, Dimitropoulos\u00a0K, Yuan\u00a0Y, Omar\u00a0MI, MacLennan\u00a0S et al (2020) Non-antibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. Urol 205(3):653\u2013663","journal-title":"J Urol"},{"issue":"2","key":"2065_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/JU.0000000000000814","volume":"204","author":"A Pilatz","year":"2020","unstructured":"Pilatz\u00a0A, Dimitropoulos\u00a0K, Veeratterapillay\u00a0R, Yuan\u00a0Y, Omar\u00a0MI, MacLennan\u00a0S et al (2020) Antibiotic prophylaxis for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. J\u00a0Urol 204(2):224\u2013230","journal-title":"J Urol"},{"issue":"1","key":"2065_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.eururo.2020.10.019","volume":"79","author":"A Pilatz","year":"2021","unstructured":"Pilatz\u00a0A, Veeratterapillay\u00a0R, Dimitropoulos\u00a0K, Omar\u00a0MI, Pradere\u00a0B, Yuan\u00a0Y et\u00a0al (2021) European association of urology position paper on the prevention of infectious complications following prostate biopsy. Eur Urol 79(1):11\u201315","journal-title":"Eur Urol"},{"key":"2065_CR9","unstructured":"Guidelines EAU (2002) EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam, 2022. ISBN 978-94-92671-16-5"},{"issue":"17","key":"2065_CR10","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1200\/JCO.2009.25.7311","volume":"28","author":"AE Ross","year":"2010","unstructured":"Ross\u00a0AE, Loeb\u00a0S, Landis\u00a0P, Partin\u00a0AW, Epstein\u00a0JI, Kettermann\u00a0A et al (2010) Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a\u00a0prostate cancer surveillance program. J\u00a0Clin Oncol 28(17):2810\u20132816","journal-title":"J Clin Oncol"},{"issue":"4","key":"2065_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.eururo.2013.05.030","volume":"64","author":"MJ Roobol","year":"2013","unstructured":"Roobol\u00a0MJ, Kranse\u00a0R, Bangma\u00a0CH, van Leenders\u00a0AG, Blijenberg\u00a0BG, van Schaik\u00a0RH et\u00a0al (2013) Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer. Eur Urol 64(4):530\u2013539","journal-title":"Eur Urol"},{"issue":"1","key":"2065_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.eururo.2009.08.025","volume":"57","author":"MJ Roobol","year":"2010","unstructured":"Roobol\u00a0MJ, Steyerberg\u00a0EW, Kranse\u00a0R, Wolters\u00a0T, van den Bergh\u00a0RC, Bangma\u00a0CH et al (2010) A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol 57(1):79\u201385","journal-title":"Eur Urol"},{"issue":"5","key":"2065_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/bju.14853","volume":"124","author":"W Venderink","year":"2019","unstructured":"Venderink\u00a0W, van Luijtelaar\u00a0A, van der Leest\u00a0M, Barentsz\u00a0JO, Jenniskens\u00a0SFM, Sedelaar\u00a0MJP et al (2019) Multiparametric magnetic resonance imaging and follow-up to avoid prostate biopsy in 4259 men. BJU Int 124(5):775\u2013784","journal-title":"BJU Int"},{"issue":"8","key":"2065_CR14","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1017\/S0950268815002885","volume":"144","author":"HY Bennett","year":"2016","unstructured":"Bennett\u00a0HY, Roberts\u00a0MJ, Doi\u00a0SA, Gardiner\u00a0RA (2016) The global burden of major infectious complications following prostate biopsy. Epidemiol Infect 144(8):1784\u20131791","journal-title":"Epidemiol Infect"},{"issue":"1","key":"2065_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bju.15039","volume":"126","author":"B Berry","year":"2020","unstructured":"Berry\u00a0B, Parry\u00a0MG, Sujenthiran\u00a0A, Nossiter\u00a0J, Cowling\u00a0TE, Aggarwal\u00a0A et al (2020) Comparison of complications after transrectal and transperineal prostate biopsy: a\u00a0national population-based study. BJU Int 126(1):97\u2013103","journal-title":"BJU Int"},{"issue":"1","key":"2065_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41391-020-0204-8","volume":"23","author":"J Grummet","year":"2020","unstructured":"Grummet\u00a0J, Gorin\u00a0MA, Popert\u00a0R, O\u2019Brien\u00a0T, Lamb\u00a0AD, Hadaschik\u00a0B et\u00a0al (2020) \u201cTREXIT 2020\u201d: why the time to abandon transrectal prostate biopsy starts now. Prostate Cancer Prostatic Dis 23(1):62\u201365","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"2065_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/JU.0000000000002251","volume":"207","author":"D Castellani","year":"2022","unstructured":"Castellani\u00a0D, Pirola\u00a0GM, Law\u00a0YXT, Gubbiotti\u00a0M, Giulioni\u00a0C, Scarcella\u00a0S et al (2022) Infection rate after transperineal prostate biopsy with and without prophylactic antibiotics: results from a\u00a0systematic review and meta-analysis of comparative studies. J\u00a0Urol 207(1):25\u201334","journal-title":"J Urol"},{"key":"2065_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.euros.2022.01.001","volume":"37","author":"SP Basourakos","year":"2022","unstructured":"Basourakos\u00a0SP, Alshak\u00a0MN, Lewicki\u00a0PJ, Cheng\u00a0E, Tzeng\u00a0M, DeRosa\u00a0AP et al (2022) Role of prophylactic antibiotics in transperineal prostate biopsy: a systematic review and meta-analysis. Eur Urol Open Sci 37:53\u201363","journal-title":"Eur Urol Open Sci"},{"issue":"10","key":"2065_CR19","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/S1473-3099(22)00373-5","volume":"22","author":"M Jacewicz","year":"2022","unstructured":"Jacewicz\u00a0M, G\u00fcnzel\u00a0K, Rud\u00a0E, Sandb\u00e6k\u00a0G, Magheli\u00a0A, Busch\u00a0J et al (2022) Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a\u00a0randomised, open-label, non-inferiority trial. Lancet Infect Dis 22(10):1465\u20131471","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"2065_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.17650\/17269776-2021-17-2-46-52","volume":"17","author":"D Chernysheva","year":"2021","unstructured":"Chernysheva\u00a0D, Popov\u00a0S, Orlov\u00a0I, Tsoy\u00a0A, Neradovskiy\u00a0V (2021) The first experience of transperineal prostate biopsy without antibiotic prophylaxis. Cancer Urol 17(2):46\u201352","journal-title":"Cancer Urol"},{"key":"2065_CR21","doi-asserted-by":"publisher","DOI":"10.3791\/52670","author":"JD Raman","year":"2015","unstructured":"Raman\u00a0JD, Lehman\u00a0KK, Dewan\u00a0K, Kirimanjeswara\u00a0G (2015) Povidone iodine rectal preparation at time of prostate needle biopsy is a\u00a0simple and reproducible means to reduce risk of procedural infection. J\u00a0Vis Exp. https:\/\/doi.org\/10.3791\/52670","journal-title":"J Vis Exp"},{"issue":"6","key":"2065_CR22","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.euf.2018.06.005","volume":"5","author":"G Salomon","year":"2019","unstructured":"Salomon\u00a0G, Prues\u00a0S, Saul\u00a0J, Budaus\u00a0L, Tilki\u00a0D, Schneider\u00a0M et\u00a0al (2019) Antimicrobial lubricant did not reduce infection rate in transrectal biopsy patients in a\u00a0large randomized trial Due to low complication rates. Eur Urol Focus 5(6):992\u2013997","journal-title":"Eur Urol Focus"},{"issue":"2","key":"2065_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5173\/ceju.2015.608","volume":"68","author":"C De Nunzio","year":"2015","unstructured":"De Nunzio\u00a0C, Lombardo\u00a0R, Presicce\u00a0F, Bellangino\u00a0M, Finazzi Agro\u00a0E, Gambrosier\u00a0MB et al (2015) Transrectal-ultrasound prostatic biopsy preparation: rectal enema vs. mechanical bowel preparation. Cent European J Urol 68(2):223\u2013228","journal-title":"Cent European J Urol"},{"key":"2065_CR24","unstructured":"Commission E (2019) https:\/\/ec.europa.eu\/transparency\/regdoc\/rep\/3\/2019\/EN\/C-2019-2050-F1-EN-ANNEX-1-PART-1.PDF. Zugegriffen: 02.03.2023"},{"issue":"2","key":"2065_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.eururo.2018.10.057","volume":"75","author":"G Bonkat","year":"2019","unstructured":"Bonkat\u00a0G, Wagenlehner\u00a0F (2019) In the line of fire: should urologists stop prescribing fluoroquinolones as default? Eur Urol 75(2):205\u2013207","journal-title":"Eur Urol"},{"issue":"2","key":"2065_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/2090598X.2019.1592636","volume":"17","author":"DMO Freitas","year":"2019","unstructured":"Freitas\u00a0DMO, Moreira\u00a0DM (2019) Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: a meta-analysis of clinical studies. Arab J Urol 17(2):114\u2013119","journal-title":"Arab J Urol"},{"issue":"2","key":"2065_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41391-018-0032-2","volume":"21","author":"J Noreikaite","year":"2018","unstructured":"Noreikaite\u00a0J, Jones\u00a0P, Fitzpatrick\u00a0J, Amitharaj\u00a0R, Pietropaolo\u00a0A, Vasdev\u00a0N et al (2018) Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 21(2):153\u2013160","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"2065_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00345-017-2163-9","volume":"36","author":"MJ Roberts","year":"2018","unstructured":"Roberts\u00a0MJ, Scott\u00a0S, Harris\u00a0PN, Naber\u00a0K, Wagenlehner\u00a0FME, Doi\u00a0SAR (2018) Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. World J Urol 36(3):323\u2013330","journal-title":"World J Urol"},{"key":"2065_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jgar.2018.11.020","volume":"17","author":"A Carignan","year":"2019","unstructured":"Carignan\u00a0A, Sabbagh\u00a0R, Masse\u00a0V, Gagnon\u00a0N, Montpetit\u00a0LP, Smith\u00a0MA et al (2019) Effectiveness of fosfomycin tromethamine prophylaxis in preventing infection following transrectal ultrasound-guided prostate needle biopsy: results from a\u00a0large Canadian cohort. J\u00a0Glob Antimicrob Resist 17:112\u2013116","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"2065_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0924-8579(00)00182-5","volume":"15","author":"F Wagenlehner","year":"2000","unstructured":"Wagenlehner\u00a0F, Stower-Hoffmann\u00a0J, Schneider-Brachert\u00a0W, Naber\u00a0KG, Lehn\u00a0N (2000) Influence of a\u00a0prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology. Int J Antimicrob Agents 15(3):207\u2013211","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"2065_CR31","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.juro.2010.11.088","volume":"185","author":"MA Liss","year":"2011","unstructured":"Liss\u00a0MA, Chang\u00a0A, Santos\u00a0R, Nakama-Peeples\u00a0A, Peterson\u00a0EM, Osann\u00a0K et al (2011) Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J\u00a0Urol 185(4):1283\u20131288","journal-title":"J Urol"},{"issue":"2-3","key":"2065_CR32","first-page":"93","volume":"21","author":"RS Concepcion","year":"2019","unstructured":"Concepcion\u00a0RS, Schaeffer\u00a0EM, Shore\u00a0ND, Kapoor\u00a0DA, Scott\u00a0JA, Kirsh\u00a0GM (2019) The effect of local antibiogram-based augmented antibiotic prophylaxis on infection-related complications following prostate biopsy. Rev Urol 21(2-3):93\u2013101","journal-title":"Rev Urol"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-023-02065-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-023-02065-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-023-02065-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T08:04:05Z","timestamp":1683187445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-023-02065-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["2065"],"URL":"https:\/\/doi.org\/10.1007\/s00120-023-02065-w","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"assertion":[{"value":"16 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Pilatz, J.\u00a0Alidjanov, G.\u00a0Bonkat und F.\u00a0Wagenlehner geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}